Diuretic enhanced ultrasonography in the diagnosis of pyeloureteral obstruction
Autor: | Marius Anglickis, Vytautas Bilius, Gilvydas Verkauskas, Andrius Čekuolis, Vytis Kazlauskas |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
Medicine (General) medicine.medical_specialty Pyeloplasty pyeloplasty Adolescent medicine.medical_treatment 030232 urology & nephrology Urology Hydronephrosis Article 03 medical and health sciences R5-920 0302 clinical medicine Furosemide medicine Humans Child Diuretics Pelvis Ultrasonography pyeloureteral junction obstruction business.industry Ultrasound Infant General Medicine diuretic renal scan medicine.disease diuretic ultrasonography hydronephrosis medicine.anatomical_structure 030220 oncology & carcinogenesis Child Preschool Female Diuretic renal scan Diuretic ultrasonography Pyeloureteral junction obstruction Diuretic business Renal pelvis medicine.drug Ureteral Obstruction |
Zdroj: | Medicina (Lithuania), Basel : MDPI AG, 2019, vol. 55, iss. 10, art. no. 670, p. [1-7] Medicina Medicina, Vol 55, Iss 10, p 670 (2019) Medicina; Volume 55; Issue 10; Pages: 670 Volume 55 Issue 10 |
ISSN: | 1010-660X 1648-9144 |
Popis: | Background and Objectives: To determine the value of diuretic ultrasonography for the diagnosis of obstructive hydronephrosis. Materials and Methods: Diuretic enhanced ultrasonography was used routinely as a part of examination of patients with hydronephrosis in our Department. There were 72 patients (42 males, 30 females aged 2 months to 17 years median age 7.07 years) with a sonoscopic diagnosis of hydronephrosis included from January 2006 until October 2011. The anteroposterior diameter (AD) of renal pelvis was measured sonoscopically before and at sixty minutes after furosemide injection. A weight-adjusted dose of 1 mg/kg of furosemide was administered intravenously. Results: Patients were operated on if pyeloureteral obstruction was suspected because of low or deteriorating differential renal function, increasing hydronephrosis or symptoms thereof. Hydronephrosis was unilateral in 61 (84.7%) and bilateral in 11 (15.3%) patients. The median AD of pelvis before furosemide injection was 22 mm in operated and 17 mm in non-operated patients (p = 0.005). Sixty minutes after furosemide injection, the AD of pelvis in operated patients was 35.5 mm and 25.8 mm in non-operated&mdash 25.8 mm (p < 0.001). Logistic regression model demonstrated that significant factors for surgery were: AD 60 minutes after furosemide infection and ultrasonographic parenchymal sclerosis. Conclusion: Ultrasound measurement of the AD of renal pelvis 1 hour after the injection of furosemide used as an additional investigation can help in predicting obstructive hydronephrosis. |
Databáze: | OpenAIRE |
Externí odkaz: |